|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.29 CHF | -1.79% |
|
-2.35% | +14.23% |
| 09:14am | Novartis raises profit target for 2024 | CF |
| 07:59am | Novartis Raises Profit Guidance as Key Drugs Boost Sales -- Update | DJ |
FRANKFURT (Reuters) - Swiss drugmaker Novartis raised its 2024 earnings guidance for the second time on Thursday, driven by a gain in prescriptions of drugs including heart failure treatment Entresto and Kesimpta for multiple sclerosis.
It said in a statement that full-year adjusted operating income is expected to grow by a "mid- to high teens" percentage, where it had previously seen a "low double-digit to mid-teens" percentage.
(Reporting by Ludwig Burger, editing by Miranda Murray)
| 1st Jan change | Capi. | |
|---|---|---|
| +14.23% | 228B | |
| +55.35% | 815B | |
| +31.56% | 597B | |
| -0.10% | 377B | |
| +15.47% | 319B | |
| +13.10% | 310B | |
| +16.06% | 247B | |
| +16.54% | 180B | |
| +4.31% | 170B | |
| +3.40% | 126B |
NOVARTIS AG 
